AVNS
Avanos Medical Inc
25.00$
+0.0%
vs. previous close
Closing price · As of: Jul 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 42.3% | 44.2% | 45.2% | 42.9% | 44.3% | 45.5% | 44.7% | 46.4% | 47.4% | 54.4% | 52.5% | 51.5% | 51.4% | |
| 57.7% | 55.8% | 54.8% | 57.1% | 55.7% | 54.5% | 55.3% | 53.6% | 52.6% | 45.6% | 47.5% | 48.5% | 48.6% | |
| 4.0% | 3.6% | 3.9% | 4.2% | 3.7% | 4.2% | 3.2% | 3.2% | 3.3% | 3.3% | 3.4% | 2.9% | 3.2% | |
| 54.9% | 45.9% | 43.0% | 50.3% | 47.1% | 43.6% | 44.4% | 45.2% | 47.7% | 43.6% | 43.6% | 42.6% | 44.4% | |
| 50.8% | 40.9% | 42.0% | 52.6% | 46.3% | 44.7% | 48.3% | 49.3% | 48.5% | 38.2% | 96.9% | 41.8% | 56.5% | |
| 7.0% | 14.9% | 12.8% | 4.5% | 9.4% | 9.8% | 7.0% | 4.4% | 4.2% | 7.4% | -49.4% | 6.7% | -7.9% | |
| 2.1% | 2.7% | 1.9% | 1.9% | 1.8% | 1.9% | 1.6% | 1.3% | 1.1% | 1.0% | 1.1% | 0.8% | 1.0% | |
| -3.0% | -1.5% | 5.1% | 0.9% | 3.6% | 5.6% | -234.1% | 5.8% | -43.4% | -0.7% | 0.7% | 4.2% | -9.5% | |
| -0.5% | 3.6% | -1.2% | 0.6% | 1.1% | 2.1% | -13.1% | 1.9% | 0.5% | 0.1% | -1.4% | 1.4% | 0.2% | |
| -40.2% | -2.2% | 6.1% | -0.5% | 1.0% | 2.5% | -221.2% | 3.9% | -43.9% | -0.8% | 2.0% | 2.8% | -9.7% | |
| 5.1% | 7.6% | 13.7% | 9.6% | 12.0% | 14.3% | -226.4% | 12.8% | -36.5% | 5.6% | 7.2% | 10.6% | -3.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.